These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23421897)

  • 21. Adapting the Abbreviated Impactor Measurement (AIM) concept to make appropriate inhaler aerosol measurements to compare with clinical data: a scoping study with the "Alberta" idealized throat (AIT) inlet.
    Mitchell J; Copley M; Sizer Y; Russell T; Solomon D
    J Aerosol Med Pulm Drug Deliv; 2012 Aug; 25(4):188-97. PubMed ID: 22857270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung deposition of budesonide from a pressurized metered-dose inhaler attached to a spacer.
    Thorsson L; Edsbäcker S
    Eur Respir J; 1998 Dec; 12(6):1340-5. PubMed ID: 9877488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in normal adults.
    Delvadia R; Hindle M; Longest PW; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):138-44. PubMed ID: 22947131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Numerical simulation of emitted particle characteristics and airway deposition distribution of Symbicort(®) Turbuhaler(®) dry powder fixed combination aerosol drug.
    Farkas Á; Jókay Á; Balásházy I; Füri P; Müller V; Tomisa G; Horváth A
    Eur J Pharm Sci; 2016 Oct; 93():371-9. PubMed ID: 27552906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler.
    Tarsin W; Assi KH; Chrystyn H
    J Aerosol Med; 2004; 17(1):25-32. PubMed ID: 15120010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro-In Vivo Correlations Observed With Indacaterol-Based Formulations Delivered with the Breezhaler®.
    Weers JG; Clark AR; Rao N; Ung K; Haynes A; Khindri SK; Perry SA; Machineni S; Colthorpe P
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):268-80. PubMed ID: 25517988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved lung delivery from a passive dry powder inhaler using an Engineered PulmoSphere powder.
    Duddu SP; Sisk SA; Walter YH; Tarara TE; Trimble KR; Clark AR; Eldon MA; Elton RC; Pickford M; Hirst PH; Newman SP; Weers JG
    Pharm Res; 2002 May; 19(5):689-95. PubMed ID: 12069174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determining factors of aerosol deposition for four pMDI-spacer combinations in an infant upper airway model.
    Janssens HM; Krijgsman A; Verbraak TF; Hop WC; de Jongste JC; Tiddens HA
    J Aerosol Med; 2004; 17(1):51-61. PubMed ID: 15120013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting Pulmonary Pharmacokinetics from In Vitro Properties of Dry Powder Inhalers.
    Bhagwat S; Schilling U; Chen MJ; Wei X; Delvadia R; Absar M; Saluja B; Hochhaus G
    Pharm Res; 2017 Dec; 34(12):2541-2556. PubMed ID: 28799097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
    Aggarwal B; Gogtay J
    Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Considerations for Designing In Vitro Bioequivalence (IVBE) Studies for Pressurized Metered Dose Inhalers (pMDIs) with Spacer or Valved Holding Chamber (S/VHC) Add-on Devices.
    Sandell D; Mitchell JP
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):156-81. PubMed ID: 25089555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of pressurized metered-dose inhalers at extreme temperature conditions.
    Morin CMD; Ivey JW; Titosky JTF; Suderman JD; Olfert JS; Vehring R; Finlay WH
    J Pharm Sci; 2014 Nov; 103(11):3553-3559. PubMed ID: 25252183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of droplet evaporation rate on resulting in vitro performance parameters of pressurized metered dose inhalers.
    Sheth P; Grimes MR; Stein SW; Myrdal PB
    Int J Pharm; 2017 Aug; 528(1-2):360-371. PubMed ID: 28599855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler.
    Ganderton D; Lewis D; Davies R; Meakin B; Church T
    Respir Med; 2003 Nov; 97 Suppl D():S4-9. PubMed ID: 14753246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma.
    Agertoft L; Pedersen S; Nikander K
    J Aerosol Med; 1999; 12(3):161-9. PubMed ID: 10623332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro drug delivery performance of a new budesonide/formoterol pressurized metered-dose inhaler.
    Chambers F; Ludzik A
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):113-20. PubMed ID: 19422311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD.
    Tronde A; Gillen M; Borgström L; Lötvall J; Ankerst J
    J Clin Pharmacol; 2008 Nov; 48(11):1300-8. PubMed ID: 18974284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the lung absorption of FK224 inhaled from a pressurized metered dose inhaler and a dry powder inhaler by healthy volunteers.
    Nakate T; Yoshida H; Ohike A; Tokunaga Y; Ibuki R; Kawashima Y
    Eur J Pharm Biopharm; 2003 Nov; 56(3):319-25. PubMed ID: 14602173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.